T40 Logo (Gilotrif 40 mg)
Generic Name: afatinib
Pill imprint T40 Logo has been identified as Gilotrif 40 mg.
Gilotrif is used in the treatment of non-small cell lung cancer and belongs to the drug class multikinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Gilotrif 40 mg is not a controlled substance under the Controlled Substance Act (CSA).
Gilotrif
- Generic Name:
- afatinib
- Imprint:
- T40 Logo
- Strength:
- 40 mg
- Color:
- Blue
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Multikinase inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Boehringer Ingelheim Pharmaceuticals, Inc.
More about Gilotrif (afatinib)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 0 Reviews – Add your own review/rating
- Drug class: multikinase inhibitors
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
